FDG: fluorodeoxyglucose LPP: lichen planopilaris PET-CT: positron emission tomographye computed tomography PD-1: programmed cell death receptor 1 P embrolizumab, a programmed cell death receptor 1 (PD-1) inhibitor, has been used effectively for treatment of metastatic melanoma. Reported cutaneous adverse events ascribed to PD-1 inhibitors include lichenoid reactions such as lichen planus of the...

background oral lichen planus (olp) is a chronic inflammatory disease affecting the oral mucosa in 0.5-2% of the world’s population. it is more common in women compared to men and the mean age at the onset of the lesion is the fourth decade. objectives the purpose of this study was to evaluate the presence of helicobacter pylori (h. pylori) in oral lichen planus and oral lichenoid reaction. mat...

Actas Dermosifiliogr. 2009;100:615-34 619 7. Menzies SW, Westerhoff K, Rabinovitz H, Kopf AW, McCar thy WH, Katz B. Sur face microscopy of pigmented basal cel l carcinoma. Arch Dermatol. 2000;136: 1012-6. 8. Zaballos P, Blázquez S, Puig S, Salsench E, Rodero J, Vives JM, et al. Dermoscopic pattern of intermediate stage in seborrhoeic keratosis regressing to lichenoid keratosis: report of 24 cas...

Background: Chronic graft versus host disease (cGVHD) is a major cutaneous complication of bone marrow transplantation (BMT). Although milder forms of this process may be associated with a lower incidence of tumor recurrences, it is mandatory to develop a more efficient and less harmful therapeutic approach.Methods: This case-series study enrolled 7 patients diagnosed w...

Background: Chronic graft versus host disease (cGVHD) is a major cutaneous complication of bone marrow transplantation (BMT). Although milder forms of this process may be associated with a lower incidence of tumor recurrences, it is mandatory to develop a more efficient and less harmful therapeutic approach.Methods: This case-series study enrolled 7 patients diagnosed with chronic mucocutaneous...

A 15 year old boy admitted with fever for 10 days associated with altered sensorium. Clinical findings and relevant investigations (including CSF study) were consistent with the diagnosis of tubercular meningitis (TBM). He was put on oral corticosteroid and CAT-.I antitubercular drugs (ATD) (Thrice weekly dosage of INH: 600mg; Rifampicin: 450mg, Ethambutol: 1200mg, Pyrazinamide: 1500mg) [Day 1]...